HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ryuhei Okuyama Selected Research
Ryuhei Okuyama Research Topics
Disease
32
Melanoma (Melanoma, Malignant)
11/2022 - 08/2004
18
Neoplasms (Cancer)
11/2022 - 08/2004
8
Neoplasm Metastasis (Metastasis)
11/2021 - 08/2004
4
Psoriasis (Pustulosis Palmaris et Plantaris)
09/2021 - 03/2011
4
Psoriatic Arthritis
01/2021 - 10/2016
4
Inflammation (Inflammations)
03/2018 - 11/2005
3
Infections
09/2020 - 01/2006
3
Atopic Dermatitis (Atopic Eczema)
10/2019 - 11/2012
3
Mycosis Fungoides
01/2017 - 01/2006
3
Wounds and Injuries (Trauma)
07/2015 - 03/2006
2
Leg Ulcer
12/2021 - 01/2011
2
Hypersensitivity (Allergy)
10/2019 - 01/2017
2
Vasculitis (Vasculitides)
02/2018 - 08/2013
2
Basal Cell Carcinoma (Rodent Ulcer)
03/2016 - 06/2014
2
Pyogenic Granuloma
03/2016 - 09/2010
1
Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2022
1
Rheumatoid Vasculitis
12/2021
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2021
1
Hypohidrosis
04/2021
1
Circulating Neoplastic Cells
03/2021
1
Brain Neoplasms (Brain Tumor)
03/2021
1
Sacroiliitis
01/2021
1
Spondylitis
01/2021
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
12/2020
1
Extramammary Paget Disease (Paget Disease, Extramammary)
11/2020
1
Ankylosing Spondylitis
01/2020
1
Dermatitis
10/2019
1
Thymoma (Thymic Carcinoma)
06/2019
1
Porphyria Cutanea Tarda
01/2019
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2018
1
Colonic Neoplasms (Colon Cancer)
01/2018
Drug/Important Bio-Agent (IBA)
9
Nivolumab
IBA
11/2022 - 01/2016
7
Biomarkers (Surrogate Marker)
IBA
11/2022 - 10/2016
6
Proteins (Proteins, Gene)
FDA Link
11/2022 - 11/2005
6
Immune Checkpoint Inhibitors
IBA
03/2021 - 01/2016
5
Ligands
IBA
11/2022 - 01/2014
5
Antibodies
IBA
07/2021 - 01/2016
4
DNA (Deoxyribonucleic Acid)
IBA
11/2019 - 10/2016
4
Ipilimumab
IBA
11/2019 - 12/2012
4
Antigens
IBA
02/2018 - 12/2012
3
pembrolizumab
IBA
11/2022 - 06/2016
3
Therapeutic Uses
IBA
11/2022 - 11/2005
3
Paclitaxel (Taxol)
FDA Link
Generic
11/2020 - 12/2013
3
Cell-Free Nucleic Acids
IBA
03/2020 - 01/2016
3
Interleukins
IBA
01/2018 - 04/2009
2
Cytokines
IBA
11/2022 - 07/2015
2
Pharmaceutical Preparations
IBA
11/2022 - 03/2021
2
Steroids
IBA
01/2022 - 01/2006
2
Neoplasm Antigens (Tumor Antigens)
IBA
07/2021 - 01/2018
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
03/2021 - 01/2014
2
Melanins (Melanin)
IBA
02/2021 - 01/2021
2
Adalimumab (Humira)
FDA Link
01/2021 - 01/2020
2
ErbB Receptors (EGF Receptor)
IBA
11/2020 - 04/2016
2
Cysteinyldopa
IBA
01/2020 - 11/2018
2
Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
IBA
10/2019 - 01/2017
2
Nerve Growth Factors (Neurotrophins)
IBA
10/2019 - 01/2017
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2018 - 08/2010
2
Immunoglobulin E (IgE)
IBA
09/2016 - 11/2005
2
5-hydroxymethylcytosine
IBA
05/2016 - 02/2014
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
04/2016 - 04/2009
2
Immunoglobulin G (IgG)
IBA
11/2014 - 04/2009
2
Lipopolysaccharides
IBA
01/2014 - 04/2009
2
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
08/2010 - 06/2006
2
Adenosine Triphosphate (ATP)
IBA
05/2010 - 04/2009
2
CPG-oligonucleotide
IBA
11/2005 - 08/2004
2
Oligodeoxyribonucleotides
IBA
11/2005 - 08/2004
1
Programmed Cell Death 1 Receptor
IBA
11/2022
1
Chemokines
IBA
11/2022
1
Etanercept (Enbrel)
FDA Link
01/2022
1
apalutamide
IBA
01/2022
1
Certolizumab Pegol
FDA Link
12/2021
1
Tissue Inhibitor of Metalloproteinase-3
IBA
11/2021
1
Cysteine (L-Cysteine)
FDA Link
11/2021
1
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
09/2021
1
Angiotensin Receptors (Angiotensin II Receptor)
IBA
07/2021
1
Carbonic Anhydrase II
IBA
04/2021
1
Lipids
IBA
03/2021
1
Fatty Acid-Binding Protein 7
IBA
03/2021
1
Catenins
IBA
03/2021
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
12/2020
1
Trastuzumab (Herceptin)
FDA Link
11/2020
1
human ERBB2 protein
IBA
11/2020
1
Voriconazole (Vfend)
FDA Link
Generic
09/2020
1
Type 1 Angiotensin Receptor
IBA
01/2020
1
C-Reactive Protein
IBA
01/2020
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
01/2020
1
Immunoglobulins (Immunoglobulin)
IBA
06/2019
1
Antiviral Agents (Antivirals)
IBA
01/2019
1
Acyclovir (Aciclovir)
FDA Link
Generic
09/2018
1
Antimicrobial Peptides
IBA
03/2018
1
Cathelicidins
IBA
03/2018
1
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
02/2018
1
B7-H1 Antigen
IBA
01/2018
1
Angiotensin Receptor Antagonists
IBA
01/2018
1
Arginase
IBA
01/2018
Therapy/Procedure
26
Therapeutics
11/2022 - 08/2004
7
Immunotherapy
01/2020 - 11/2005
3
Molecular Targeted Therapy
03/2021 - 11/2012
2
Combination Drug Therapy (Combination Chemotherapy)
11/2020 - 12/2013
1
Transplantation
09/2018